Shire

In 1986 was created Shire, which is appeared as Corporate Investor. The company was established in Europe in Ireland. The main department of described Corporate Investor is located in the Dublin.

The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this Corporate Investor is 2 percentage points less often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2019. Comparing to the other companies, this Shire performs on 20 percentage points less the average number of lead investments. The top activity for fund was in 2012.

Among the most popular portfolio startups of the fund, we may highlight Promedior, Promethera Biosciences, Proclara Biosciences. The fund has exact preference in some founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Pharmaceutical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Shire, startups are often financed by Merieux Developpement, GV, PathoCapital. The meaningful sponsors for the fund in investment in the same round are Merieux Developpement, Mitsui Global Investment, Boehringer Ingelheim Venture Fund. In the next rounds fund is usually obtained by Merieux Developpement, Vesalius Biocapital Partners, Takeda Ventures.

Notable deals

Review

• No reviews are submitted yet.